Related Experiment Video
Updated: Jul 14, 2026
06:44
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
Improved detection of skull metastasis with diffusion-weighted MR imaging
A J Nemeth1, J W Henson, M E Mullins
1Neuroradiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
AJNR. American Journal of Neuroradiology
|June 16, 2007
Summary
Diffusion-weighted MR imaging (DWI) significantly improves skull metastasis detection for breast and lung cancers compared to conventional MR imaging. However, DWI is insensitive for detecting skull metastases originating from prostate carcinoma.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Skull metastasis detection is clinically significant.
- Conventional MR imaging has moderate sensitivity for skull metastasis.
- Diffusion-weighted MR imaging (DWI) may offer improved detection.
Purpose of the Study:
- To evaluate if DWI enhances skull metastasis detection.
- Comparison between DWI and conventional MR imaging.
- Focus on patients with primary bone-metastasizing carcinomas.
Main Methods:
- Retrospective analysis of 75 patients with extracranial malignancy.
- Comparison of DWI and conventional MR imaging against radionuclide bone scanning (RNBS) as the gold standard.
- Two readers correlated imaging findings with RNBS results.
Main Results:
- DWI sensitivity (68.4%-71.1%) surpassed conventional MR imaging (42.1%-55.3%).
- Breast cancer metastasis detection was highest with DWI (86.7%-93.3%).
- DWI showed improved sensitivity for lung cancer (63.6%-72.7%) but was insensitive for prostate cancer.
Conclusions:
- DWI is a valuable tool for detecting skull metastases from breast and lung cancers.
- DWI offers superior detection compared to conventional MR imaging for these malignancies.
- DWI is not effective for identifying skull metastases from prostate carcinoma.
